Study analysis · The British journal of general practice : the journal of the Royal College of General Practitioners · 2026

Mediterranean diet linked to 60% lower relative risk of cardiovascular death in heart disease patients—but the absolute benefit remains unknown.

For people who already have heart disease, a Mediterranean-style diet may lower the relative risk of dying from heart problems, but randomized trials overall showed no clear benefit from any single diet.

Reading level
Very low certainty
Level 2a · Systematic review of cohort studiesAssociation, not causationNo causal claims

Overview

What the study found

The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.

In simple terms

This study combines many smaller studies to see if healthy eating advice helps people who already have heart disease. It found that some diets, like the Mediterranean diet, might help, but the evidence isn't strong enough to say for sure that diet directly causes better outcomes. It's like gathering lots of opinions, but some are more reliable than others.

What’s the bottom line?

Researchers combined many studies to see if diet advice helps people with existing heart disease. They looked at randomized trials and long-term observational studies. Overall, no single diet clearly reduced death or heart problems in the randomized trials, but a Mediterranean diet seemed to lower heart-related deaths. In observational studies, people who ate healthier diets (mostly Mediterranean) had lower risks of dying or having another heart problem. However, the absolute risk reduction (how many fewer people actually had events) was not reported, and studies were mixed in quality.

How strong is this study?

The researchers tried to be thorough by looking at many studies and checking their quality, but many of the included studies had problems like bias or didn't follow people long enough. Also, we only saw a short summary, not the full details, so it's hard to know how well everything was done. This means we should be cautious about trusting the results completely.

Reporting

0 / 100

  • COI disclosureconflicts of interest not disclosed
  • Data availabilitydata not shared
  • Code availabilitycode not shared
Methodology

0 / 100

  • Randomizationnot randomized
  • Blindingnot blinded
  • Control groupno control group
  • Sample sizeno sample size reported
  • Follow-upno follow-up reported
Publication

100 / 100

Statistical

54 / 100

  • P-valuesno p-values reported
  • Effect size+20/20
  • Confidence intervals+15/15
  • Pre-registrationnot pre-registered

Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.

Where it sits

RCT reviews

Max 100

Randomized Trials

Max 90

Reviews of Cohort Studies

Max 85

Cohort Studies

Max 72

Reviews of Case-Control Studies

Max 63

Case-Control Studies

Max 58

Cross-Sectional & Case Series

Max 50

Expert Opinion

Max 5
StrongerWeaker
Reviews of Cohort Studies
Level 2a
33

33 / 100

Probability of being correct

Systematic reviews and meta-analyses of cohort studies. They sit above a single cohort study but below a single randomized trial, because the underlying evidence is still observational.

This design cannot establish causation — the findings describe an association, not a cause. Although this is a systematic review that includes RCTs, it also includes prospective cohort studies, and the overall certainty is limited by high risk of bias, considerable heterogeneity, and abstract-only reporting. The pooled RCT results for most dietary interventions were null, and only a stratified analysis of Mediterranean diet showed a significant effect. Therefore, causation cannot be established from this review as a whole.

COI Unknown

Could not determine conflict of interest status

No conflict of interest or funding information provided in the abstract.

The provided text is only the abstract, lacking declarations, funding, or author affiliation sections. No conflicts can be assessed.

Key takeaways

  1. 01

    In randomized trials (14 trials, 14,065 patients), no diet significantly affected death or heart outcomes overall.

  2. 02

    But Mediterranean diet reduced CVD death by 60% relative risk (RR 0.40; 95% CI 0.19–0.83).

  3. 03

    In 22 cohort studies (104,386 patients), healthier diet adherence was linked to 29% lower relative risk of all-cause death (RR 0.71), 25% lower relative risk of CVD death (RR 0.75), and 17% lower relative risk of another CVD event (RR 0.83).

  4. 04

    Absolute risk reductions were not reported in the abstract.

  5. 05

    The relative risk reductions are large, but without absolute risk data (how many people per 1,000 actually avoided an event) we cannot say how much real-world benefit an individual would get.

  6. 06

    The abstract does not report absolute risk difference.

  7. 07

    The evidence is also limited by high heterogeneity and risk of bias, so the true effect may be smaller or uncertain.

Practical takeaways

If you have established cardiovascular disease, discuss a Mediterranean-style dietary pattern with your GP or healthcare provider as part of secondary prevention.

Abstract-only analysis; pooled RCTs showed no single diet significantly impacted mortality/CVD outcomes; absolute risk reductions not reported; evidence limited by high heterogeneity and risk of bias. Full paper not available.

low confidence

Why this study matters

Pooled RCTs: No Single Diet Clearly Moved Mortality Outcomes

In 14 RCTs (14,065 CVD patients), pooled results showed no dietary intervention—fat-replacement, Mediterranean, low-fat, low-sodium, or high-fibre—significantly impacted all-cause mortality, CVD mortality, or CVD recurrence compared with minimal/no advice. This null pooled result is a relative finding; absolute risk differences were not reported in the abstract.

It challenges the idea that any one diet is a magic bullet after a heart disease diagnosis.

Mediterranean Diet Subgroup: 60% Relative Lower CVD Mortality

A stratified meta-analysis of RCTs found Mediterranean diet reduced CVD mortality: RR 0.40 (95% CI 0.19–0.83), a 60% relative risk reduction. This is a relative effect; absolute risk reduction was not reported in the abstract. The finding comes from subgroup analysis and is limited by high heterogeneity and risk of bias.

A huge relative risk reduction sounds impressive, but without absolute numbers it’s hard to know how many people actually benefit.

Cohort Studies: Healthy Diet Adherence Linked to Lower Relative Risks

In 22 prospective cohorts (104,386 CVD patients), greatest adherence to healthy dietary patterns—predominantly Mediterranean—was associated with lower relative risks: all-cause mortality RR 0.71 (29% lower), CVD mortality RR 0.75 (25% lower), CVD recurrence RR 0.83 (17% lower). These are observational associations; absolute risk differences not reported.

It suggests long-term eating patterns, not just short-term interventions, may matter for people with heart disease.

Evidence Quality Caveats: High Heterogeneity and Bias Risk

Between-study heterogeneity was considerable (RCTs I²=34–60%, cohorts I²=49–76%), partly explained by geography. Risk of bias: 65% of RCTs had 'some concerns'; 52% of cohorts had high risk of bias. The abstract notes cogent studies with clearly defined diets are required.

It shows why headlines about diet and heart health should be read with caution.

Want the whole report?

Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.

Standing

Who’s using this study?

The videos and claims on this site that lean on this study, and the researchers who wrote it.

1 video from Dr Brad Stanfield cite this study, drawing 1 claim from it.

Dr Brad Stanfield
Supports
All 1 video reference this study through extracted claims.

Authored by

4 researchers

If this is your work, this is how we attribute it on Fit Body Science. Aaron Goldberg is listed as the lead author.